Chembio Diagnostics, Inc.
CEMIDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001092662
Chembio Diagnostics, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on May 2, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $1.36M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Chembio Diagnostics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 43 | 36 | −7 |
| Shares | 4.02M | 2.84M | −1.18M (−29.4%) |
| Value | $4.58M | $2.32M | −$2.26M (−49.3%) |
New holders (4)
Institutions that held Chembio Diagnostics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 124,750 | $102.0K | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $8.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 7,282 | $6.00K | 0.00% |
| Tucker Asset Management LLC | 500 | $410 | 0.00% |
Sold out (11)
Institutions that held Chembio Diagnostics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Goldman Sachs Group Inc | 92,168 | $105.0K |
| Millennium Management LLC | 47,103 | $54.0K |
| Two Sigma Securities, LLC | 35,905 | $41.0K |
| XTX Topco Ltd | 19,529 | $22.0K |
| HRT Financial LP | 18,957 | $21.0K |
| PEAK6 Investments LLC | 16,083 | $18.0K |
| Price T Rowe Associates Inc | 15,200 | $17.0K |
| Wolverine Trading, LLC | 13,173 | $15.0K |
| UBS Group AG | 10,294 | $12.0K |
| Bank of America Corp | 153 | $0 |
| FMR LLC | 339 | $0 |